Gene Therapy & RNA Therapeutics are redefining the future of disease treatment by targeting conditions at their genetic root. Gene therapy introduces functional genes into patients' cells to correct genetic mutations, using viral or non-viral vectors to deliver therapeutic DNA. Simultaneously, RNA-based drugs—such as siRNA, mRNA, and antisense oligonucleotides—are being used to silence, replace, or modulate gene expression with high specificity. Recent advances include mRNA vaccines and gene-editing platforms like CRISPR for correcting single-gene disorders. Gene Therapy & RNA Therapeutics are proving effective against cancer, rare genetic diseases, and neurodegenerative disorders. As delivery mechanisms and regulatory frameworks evolve, these molecular approaches are becoming more accessible and personalized, with potential to revolutionize preventive, curative, and precision medicine.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Engineering the future biotech workforce: A predictive framework for capability, reliability and digital innovation
Jason Beckwith, Biotalent, United Kingdom
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Degradation of atrazine by an encapsulated enzyme cascade
Maya Mowery Evans, Colorado School of Mines, United States
Title : Genomic and structural analysis to decipher xylanolytic potential in bacteria
Abhijit Reang, Tripura University, India
Title : Lignocellulosic biomass to biofuels and biochemicals: Microbial innovations for a sustainable future
Gunjan Mukherjee, Chandigarh University, India